Extensive immunization programs have led to a marked reduction in the incidence of congenital rubella syndrome in the United States, with fewer than 10 cases per year reported since 1981. However, several hundred cases of rubella are still reported each year, and over 60% of these occur in persons 15 years of age or older (3) . Therefore, it is important to continue to monitor the immune status of females of childbearing age and to confirm suspected infections. The availability of reliable, cost-effective laboratory tests is vital to both screening and diagnosis.
Various serological methods are in wide use for the detection and quantification of rubella antibodies. Among these are hemagglutination inhibition (HAI), enzyme-linked immunosorbent assay (ELISA), and passive latex agglutination (PLA). In this study, the ELISA and the PLA were each compared with a standard HAI for sensitivity, specificity, and agreement.
A total of 500 sera submitted consecutively to the New Mexico Scientific Laboratory Division were tested by the three methods. The sera were submitted primarily for the purpose of obtaining assistance in immunization decisions and for monitoring the level of rubella immunity in the New Mexico female population. The sera were first tested by ELISA and then stored at 4°C for no longer than 3 days until subsequent testing by HAI and PLA. All specimens were coded, and comparative results were unknown until tabulation of all data.
The Rubazyme test kit (Abbott Laboratories, North Chicago, Ill.) was used to perform the ELISA test, according to the procedure of the manufacturer for immune status (1) Table 2) .
The data presented indicated that both the PLA and ELISA were accurate (and reliable) methods for rubella immunity screening, as previously shown by other workers (6) (7) (8) . Their results are consistent.with the observation that rubella antibodies measured by PLA and ELISA appear in parallel with antibodies detected by HAI after both natural infection and immunization (7) .
In the present study, the proportion of false-negative ELISA results among HAI-positive serum samples was 5.3% (24 of 452). However, in studies where borderline specimens (0.500 c Rubazyme Index c 1.499) near the cut-off value were studied, this figure was 41.0% (103 of 251) (10) .
Of interest were positive ELISA results for 4.6% (2 of 43) of the HAI-negative serum samples. This is similar to an earlier report of 4.3% (14 of 148) false-positive Rubazyme test results for borderline specimens (10) . In contrast, Kleeman and colleagues, using a different commercial ELISA kit, found 39% (34 of 87) HAI-negative, ELISA-positive serum samples (5). They concluded that newer, more sensitive methods will detect low-level rubella antibodies which are undetected by HAI.
Agreement between PLA and HAI was high (99.2%), with no observed difference in sensitivity. These findings are consistent with those of Meegan and co-workers, who found 97.5% agreement, with a discrepancy in 8 of 276 serum samples, which were HAI negative and PLA positive (6) . Like (10) . Both methods have distinct technical advantages over HAI, such as no serum pretreatment and a much shorter time until reporting. The PLA method is especially simple and rapid, being readable after an 8-min incubation period.
Both the PLA and ELISA methods for detection of rubella antibodies have reached acceptance in clinical laboratories in a relatively short period of time. In the 1978-1980 College of American Pathologists survey, 45% of the laboratories testing for rubella reported using HAI (9) . However, the 1982 College of American Pathologists survey showed that HAI was used for only 19% of rubella testing. ELISA was used for 13% (Rubazyme, 10%), PLA was used for 25%, passive hemagglutination was used for 29%, indirect fluorescent-antibody assays were used for 11%, and radioimmunoassay was used for 3%. This switch from HAI to other techniques has come about because of the speed, accuracy, reliability, and cost savings which the newer methods offer.
